Oral contraception

2 trials MedDRA PT
2 Registered trials
0 Recruiting
2 Unique sponsors
1 Unique IMPs
1 Commercial trials
Drug classes (ATC)
ATC code not specified 1
G Urology/Gynaecology (ATC G) 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 1 substance
Phase III: 1 Other: 1

Filter these 2 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 2 trials

Phase III

1 trial
  • Leiden University Medical Center Academic
    MIFEPRISTONE
    2022-502694-41-00 1 country 2025 n=1,186
    Ended

Other

1 trial
  • Pevisal Group Farmaceutici S.r.l. Commercial
    IMP not specified
    2025-524871-22-00 1 country n=24
    Pending
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Pevisal Group Farmaceutici S.r.l. Commercial 1 Other 0
Leiden University Medical Center Academic 1 Phase III 0
New trials by year
2025
1
← All indication landscapes